Trial Profile
A study in healthy, young adults and healthy infants of the safety, tolerability, and immunogenicity of an investigational manufacturing process for the recombinant hepatitis B vaccine.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 26 May 2011
Price :
$35
*
At a glance
- Drugs Hepatitis B vaccine recombinant (Primary)
- Indications Hepatitis B
- Focus Pharmacodynamics
- Sponsors Merck & Co
- 26 May 2011 New trial record